$NDAQ

Smith Bryan Everard sold $148K of NDAQ

Smith Bryan Everard (EVP, CPO) sold 1,556 shares of NASDAQ, INC. (NDAQ) at $95.07 ($0.15M total) on 2026-08-03 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Bryan Everard
Published Aug 5, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:26 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$NDAQ
Neutral
high confidence
Mentioned
$NDAQ
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NDAQNeutralLow
01

Why it matters

The disclosure updates the record of insider activity but does not introduce new information about revenue, earnings, regulation, or strategy.

02

Market read

Traders may note insider selling, but the 10b5-1 framing typically reduces interpretive weight.

03

What to watch

The article provides only the sale details; it does not include any offsetting buys, changes in guidance, or other fundamental developments.

Relevance 3/10Novelty 2/10Timing: filed 2026-08-05, transaction dated 2026-08-03

Background

The article is a SEC Form 4 insider transaction for NASDAQ, Inc. (NDAQ) by Smith Bryan Everard, EVP and CPO.

Company-level read

Ticker impact

$NDAQNeutralHigh confidence
Context

NDAQ discloses an EVP/CPO open-market sale of 1,556 shares at $95.07 under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new company-specific operational or financial information.

Market effects

Minimal, as the disclosure is company-specific insider selling without sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Insider sales can still reflect personal liquidity needs rather than bearish expectations, especially when executed under a 10b5-1 plan.

Key entities

  • NASDAQ, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Smith Bryan Everard

    EVP, CPO who sold 1,556 shares at $95.07 under a pre-arranged 10b5-1 plan.

Related articles

$NDAQMed

SEC sets Aug. 24 deadline in Nasdaq Bitcoin options review

The SEC ordered a full Commission review of Nasdaq PHLX’s proposed cash-settled Bitcoin index options (QBTC), after CME Group petitioned against a May 22 staff approval. The SEC set Aug. 24 as the deadline for written comments. The May approval remains stayed pending the Commission’s next order, with CFTC and OCC relief still required.

$CMEMed

CME Challenges Nasdaq Bitcoin Options Approval, Claims CFTC Has Exclusive Jurisdiction — BigGo Finance

CME Group challenged the SEC’s conditional approval of Nasdaq PHLX’s cash-settled bitcoin index options (ticker QBTC). CME says bitcoin is a commodity, so CFTC has exclusive jurisdiction, and the SEC exceeded its authority. The SEC initiated review and kept a stay. Comments are due Aug. 24. QBTC uses CME CF Bitcoin Real-Time Index and is cash-settled in USD.

$NDAQMedAI 8/10

Nasdaq (NDAQ) Q2 2026 Earnings Call Transcript

Nasdaq (NDAQ) reported Q2 2026 net revenue of $1.5 billion, up 15%, and non-GAAP EPS of $1.07, up 25%. Solutions revenue rose 17% to $1.2 billion, with Index AUM reaching $1.114 trillion and $51 billion in quarterly net inflows. The company updated non-GAAP operating expense guidance to $2.530 billion to $2.570 billion and repurchased $356 million of shares.

$NDAQMedAI 9/10

Nasdaq Q2 Earnings: Double-Digit Revenue Growth Across All Divisions

Nasdaq (NDAQ) reported Q2 results with quarterly net revenue of $1.5 billion, up 15% on an adjusted basis. Solutions revenue rose 17% adjusted. ARR increased 11% to $3.3 billion. GAAP diluted EPS was $0.89, up 14%, and non-GAAP EPS was $1.07. Nasdaq also cited record Index AUM and IPO activity, including SpaceX.